Systems, methods, and other embodiments associated with business process diagram component analysis are described. Also disclosed are pharmaceutical compositions comprising a compound which inhibits \u03b2-amyloid peptide release andor its synthesis as well as methods for treating Alzheimer’s disease both prophylactically and therapeutically with such pharmaceutical compositions. The first set of code has a first floating point operation, thereby obtaining an emulated result.